Literature DB >> 17764776

Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.

Charlene A Wong1, Maria Rosario G Araneta, Elizabeth Barrett-Connor, John Alcaraz, Donna Castañeda, Carol Macera.   

Abstract

BACKGROUND: Studies have shown alanine aminotransferase (ALT), a marker for non-alcoholic fatty liver disease (NAFLD), predicts type 2 diabetes (T2DM).
OBJECTIVE: To examine the association between probable NAFLD and T2DM in non-obese, non-alcoholic consuming Filipino-American women aged 48-73 years. RESEARCH DESIGN AND METHODS: The UCSD Filipino Women's Health Study measured glucose, hepatic enzymes, adiponectin and visceral fat (VAT) during clinical visits (1995-2002). We defined T2DM by 1999 WHO criteria and probable NAFLD as ALT >31 U/L.
RESULTS: Prevalence of T2DM was 34.4% and probable NAFLD was 17.2%. Women with T2DM (n=56) had higher VAT, total:HDL cholesterol, SBP, fasting glucose and insulin, postchallenge glucose, ALT (28.7 U/L versus 19.1 U/L, p<0.0001), GGT, AST, and probable NAFLD (32.1% versus 9.35%, p=0.0002) and lower adiponectin than those without T2DM (n=107). GGT (p=0.0008) and ALT (p=0.002) were associated with increasing VAT levels. Probable NAFLD was independently associated with T2DM (AOR 6.32, 95% CI 2.2-18.0), after adjusting for risk factors.
CONCLUSION: Probable NAFLD was elevated and associated with T2DM, independent of VAT, adiponectin and other risk factors. ALT may serve as a useful marker for NAFLD or diabetes risk in Filipino women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764776      PMCID: PMC4512638          DOI: 10.1016/j.diabres.2007.07.012

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  44 in total

1.  Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Takahisa Eguchi; Toshihiko Mizuta; Yasushi Ide; Tsutomu Yasutake; Ryuichi Iwakiri; Akitaka Hisatomi; Iwata Ozaki; Kyousuke Yamamoto; Yoichiro Kitajima; Yasunori Kawaguchi; Shigetaka Kuroki; Naofumi Ono
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

2.  Liver biopsy:complications and risk factors.

Authors:  Pornpen Thampanitchawong; Teerha Piratvisuth
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

3.  The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group.

Authors: 
Journal:  Prev Med       Date:  1976-06       Impact factor: 4.018

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

Review 6.  The evolving role of leptin and adiponectin in chronic liver diseases.

Authors:  Emmanuel Tsochatzis; George V Papatheodoridis; Athanasios J Archimandritis
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

7.  Plasma adiponectin decrease in women with nonalcoholic Fatty liver.

Authors:  Miyao Matsubara
Journal:  Endocr J       Date:  2004-12       Impact factor: 2.349

8.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.

Authors:  Pouneh Mofrad; Melissa J Contos; Mahmadul Haque; Carol Sargeant; Robert A Fisher; Velimir A Luketic; Richard K Sterling; Mitchell L Shiffman; Richard T Stravitz; Arun J Sanyal
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

Review 9.  Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

Authors:  Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

10.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  6 in total

1.  Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects.

Authors:  Zheng Chen; Cheng-Kun Han; Ling-Ling Pan; Hui-Jie Zhang; Zhi-Min Ma; Zhu-Feng Huang; Shi Chen; Xiong-Jie Zhuang; Zhi-Bin Li; Xiao-Ying Li; Xue-Jun Li; Shu-Yu Yang
Journal:  Dig Dis Sci       Date:  2014-05-27       Impact factor: 3.199

Review 2.  A systematic review of overweight, obesity, and type 2 diabetes among Asian American subgroups.

Authors:  Lisa R Staimez; Mary Beth Weber; K M Venkat Narayan; Reena Oza-Frank
Journal:  Curr Diabetes Rev       Date:  2013-07

3.  Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice.

Authors:  Chih-Hung Guo; Wen-Long Chen; Chung-Huei Liao; Karin Huang; Pei-Yin Chen; Chun-Pai Yang
Journal:  Int J Med Sci       Date:  2018-07-30       Impact factor: 3.738

4.  Engaging the ASEAN Diaspora: Type 2 Diabetes Prevalence, Pathophysiology, and Unique Risk Factors among Filipino Migrants in the United States.

Authors:  Maria Rosario Araneta
Journal:  J ASEAN Fed Endocr Soc       Date:  2019-11-09

5.  Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease.

Authors:  Xingchun Wang; Bangfeng Zhao; Hang Sun; Hui You; Shen Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055

6.  Metabolic dysfunction-related liver disease as a risk factor for cancer.

Authors:  Alasdair Taylor; Moneeza K Siddiqui; Philip Ambery; Javier Armisen; Benjamin G Challis; Carolina Haefliger; Ewan R Pearson; Alex S F Doney; John F Dillon; Colin N A Palmer
Journal:  BMJ Open Gastroenterol       Date:  2022-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.